Literature DB >> 33711310

Endothelial Nitric Oxide Synthase-Deficient Mice: A Model of Spontaneous Cerebral Small-Vessel Disease.

Francesca-Fang Liao1, Geng Lin2, Xingyong Chen3, Ling Chen4, Wei Zheng2, Rajendra Raghow5, Fu-Ming Zhou5, Andy Y Shih6, Xing-Lin Tan7.   

Abstract

Age-related cerebral small-vessel disease (CSVD) is a major cause of stroke and dementia. Despite a widespread acceptance of small-vessel arteriopathy, lacunar infarction, diffuse white matter injury, and cognitive impairment as four cardinal features of CSVD, a unifying pathologic mechanism of CSVD remains elusive. Herein, we introduce partial endothelial nitric oxide synthase (eNOS)-deficient mice as a model of age-dependent, spontaneous CSVD. These mice developed cerebral hypoperfusion and blood-brain barrier leakage at a young age, which progressively worsened with advanced age. Their brains exhibited elevated oxidative stress, astrogliosis, cerebral amyloid angiopathy, microbleeds, microinfarction, and white matter pathology. Partial eNOS-deficient mice developed gait disturbances at middle age, and hippocampus-dependent memory deficits at older ages. These mice also showed enhanced expression of bone morphogenetic protein 4 (BMP4) in brain pericytes before myelin loss and white matter pathology. Because BMP4 signaling not only promotes astrogliogenesis but also blocks oligodendrocyte differentiation, we posit that paracrine actions of BMP4, localized within the neurovascular unit, promote white matter disorganization and neurodegeneration. These observations point to BMP4 signaling pathway in the aging brain vasculature as a potential therapeutic target. Finally, because studies in partial eNOS-deficient mice corroborated recent clinical evidence that blood-brain barrier disruption is a primary cause of white matter pathology, the mechanism of impaired nitric oxide signaling-mediated CSVD warrants further investigation.
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33711310      PMCID: PMC8647425          DOI: 10.1016/j.ajpath.2021.02.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   5.770


  97 in total

1.  Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.

Authors:  T Wyss-Coray; C Lin; D A Sanan; L Mucke; E Masliah
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

Review 3.  Bone Morphogenetic Proteins: Inhibitors of Myelination in Development and Disease.

Authors:  Judith B Grinspan
Journal:  Vitam Horm       Date:  2015       Impact factor: 3.421

4.  Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease.

Authors:  Edgard Verdura; Dominique Hervé; Eva Scharrer; Maria Del Mar Amador; Lucie Guyant-Maréchal; Anne Philippi; Astrid Corlobé; Françoise Bergametti; Steven Gazal; Carol Prieto-Morin; Nathalie Beaufort; Benoit Le Bail; Irina Viakhireva; Martin Dichgans; Hugues Chabriat; Christof Haffner; Elisabeth Tournier-Lasserve
Journal:  Brain       Date:  2015-06-10       Impact factor: 13.501

5.  Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis.

Authors:  Xuming Dai; James E Faber
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

Review 6.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

7.  Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology.

Authors:  Susan A Austin; Anantha V Santhanam; David J Hinton; Doo-Sup Choi; Zvonimir S Katusic
Journal:  J Neurochem       Date:  2013-06-27       Impact factor: 5.372

Review 8.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

Review 9.  Endothelial NOS: perspective and recent developments.

Authors:  Victor Garcia; William C Sessa
Journal:  Br J Pharmacol       Date:  2018-12-09       Impact factor: 8.739

Review 10.  Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

Authors:  Andrew J Farrall; Joanna M Wardlaw
Journal:  Neurobiol Aging       Date:  2007-09-14       Impact factor: 4.673

View more
  4 in total

1.  White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency.

Authors:  Xingyong Chen; Ling Chen; Geng Lin; Zhengjun Wang; Mahesh C Kodali; Mingqi Li; Huimin Chen; Sarah G Lebovitz; Tyler C Ortyl; Lexiao Li; Saifudeen Ismael; Purnima Singh; Kafait U Malik; Tauheed Ishrat; Fu-Ming Zhou; Wei Zheng; Francesca-Fang Liao
Journal:  Mol Psychiatry       Date:  2022-08-10       Impact factor: 13.437

Review 2.  Endothelial Dysfunction and Hyperhomocysteinemia-Linked Cerebral Small Vessel Disease: Underlying Mechanisms and Treatment Timing.

Authors:  Shuang Li; Guangjian Li; Xia Luo; Yan Huang; Lan Wen; Jinglun Li
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

3.  Non-invasive in situ Visualization of the Murine Cranial Vasculature.

Authors:  Jared S Rosenblum; Anthony J Cappadona; Pashayar P Lookian; Vikram Chandrashekhar; Jean-Paul Bryant; Vibhu Chandrashekhar; David Y Zhao; Russell H Knutsen; Danielle R Donahue; Dorian B McGavern; Beth Kozel; John D Heiss; Zhengping Zhuang
Journal:  Cell Rep Methods       Date:  2022-01-24

4.  Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C.

Authors:  Mikko T Huuskonen; Yaoming Wang; Angeliki Maria Nikolakopoulou; Axel Montagne; Zhonghua Dai; Divna Lazic; Abhay P Sagare; Zhen Zhao; Jose A Fernandez; John H Griffin; Berislav V Zlokovic
Journal:  J Exp Med       Date:  2021-11-30       Impact factor: 17.579

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.